|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens kallikrein-related peptidase 6 DNA.|
|hK6, Bssp, Klk7, SP59, PRSS9, PRSS18, MGC9355, KLK6|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human KLK6 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG12142-G-F|
|Human KLK6 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG12142-G-H|
|Human KLK6 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG12142-G-M|
|Human KLK6 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG12142-G-N|
|Human KLK6 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG12142-G-Y|
|Product name||Product name|
KLK6 (kallikrein-related peptidase 6), also known as Klk7, belongs to the peptidase S1 family, Kallikrein subfamily. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK6 is a serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Klk7 shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. KLK6 degrades alpha-synuclein and prevents its polymerization, indicating that KLK6 may be involved in the pathogenesis of Parkinson disease and other synucleinopathies. Klk7 may be involved in regulation of axon outgrowth following spinal cord injury. Tumor cells treated with a neutralizing KLK6 antibody migrate less than control cells, suggesting a role in invasion and metastasis.